294 related articles for article (PubMed ID: 9502772)
1. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.
Lomri A; Lemonnier J; Hott M; de Parseval N; Lajeunie E; Munnich A; Renier D; Marie PJ
J Clin Invest; 1998 Mar; 101(6):1310-7. PubMed ID: 9502772
[TBL] [Abstract][Full Text] [Related]
2. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
Lemonnier J; Delannoy P; Hott M; Lomri A; Modrowski D; Marie PJ
Exp Cell Res; 2000 Apr; 256(1):158-67. PubMed ID: 10739663
[TBL] [Abstract][Full Text] [Related]
3. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
Lemonnier J; Haÿ E; Delannoy P; Lomri A; Modrowski D; Caverzasio J; Marie PJ
J Bone Miner Res; 2001 May; 16(5):832-45. PubMed ID: 11341328
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria.
de Pollak C; Arnaud E; Renier D; Marie PJ
J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray.
Lomri A; Lemonnier J; Delannoy P; Marie PJ
J Bone Miner Res; 2001 Apr; 16(4):705-12. PubMed ID: 11315998
[TBL] [Abstract][Full Text] [Related]
6. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
[TBL] [Abstract][Full Text] [Related]
7. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency.
Greenwald JA; Mehrara BJ; Spector JA; Warren SM; Crisera FE; Fagenholz PJ; Bouletreau PJ; Longaker MT
J Bone Miner Res; 2000 Dec; 15(12):2413-30. PubMed ID: 11127206
[TBL] [Abstract][Full Text] [Related]
8. Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis.
Miraoui H; Ringe J; Häupl T; Marie PJ
Hum Mol Genet; 2010 May; 19(9):1678-89. PubMed ID: 20124286
[TBL] [Abstract][Full Text] [Related]
9. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
[TBL] [Abstract][Full Text] [Related]
10. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis).
De Pollack C; Renier D; Hott M; Marie PJ
J Bone Miner Res; 1996 Mar; 11(3):401-7. PubMed ID: 8852951
[TBL] [Abstract][Full Text] [Related]
11. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
Ignelzi MA; Wang W; Young AT
J Bone Miner Res; 2003 Apr; 18(4):751-9. PubMed ID: 12674336
[TBL] [Abstract][Full Text] [Related]
13. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific.
Debiais F; Hott M; Graulet AM; Marie PJ
J Bone Miner Res; 1998 Apr; 13(4):645-54. PubMed ID: 9556064
[TBL] [Abstract][Full Text] [Related]
14. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
15. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
Ratisoontorn C; Fan GF; McEntee K; Nah HD
Connect Tissue Res; 2003; 44 Suppl 1():292-7. PubMed ID: 12952211
[TBL] [Abstract][Full Text] [Related]
16. Role of the extracellular matrix and growth factors in skull morphogenesis and in the pathogenesis of craniosynostosis.
Carinci P; Becchetti E; Bodo M
Int J Dev Biol; 2000; 44(6):715-23. PubMed ID: 11061436
[TBL] [Abstract][Full Text] [Related]
17. The BMP antagonist noggin regulates cranial suture fusion.
Warren SM; Brunet LJ; Harland RM; Economides AN; Longaker MT
Nature; 2003 Apr; 422(6932):625-9. PubMed ID: 12687003
[TBL] [Abstract][Full Text] [Related]
18. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
[TBL] [Abstract][Full Text] [Related]
19. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders.
Fragale A; Tartaglia M; Bernardini S; Di Stasi AM; Di Rocco C; Velardi F; Teti A; Battaglia PA; Migliaccio S
Am J Pathol; 1999 May; 154(5):1465-77. PubMed ID: 10329600
[TBL] [Abstract][Full Text] [Related]
20. Apert p.Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells.
Fanganiello RD; Sertié AL; Reis EM; Yeh E; Oliveira NA; Bueno DF; Kerkis I; Alonso N; Cavalheiro S; Matsushita H; Freitas R; Verjovski-Almeida S; Passos-Bueno MR
Mol Med; 2007; 13(7-8):422-42. PubMed ID: 17622301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]